Eligible participant has to fullfill all of the following items | / / / / |
Anyone with one of following items or more should be excluded: | / / / / / / / / |
- General information
- Medical history
- Physical examination
- Blood Routine Tests
- Urine Routine Test
- Blood Electrolytes Tests
- Coagulation Function Tests
- Serum Liver Function Tests
- HBV/HCV/HIV/Syphilis Markers Test
- Renel Function Test
- D-dimer
- hCG Test
- Image Examinations
- Visual Analogue Scale
- Blood Gas Analysis
Date of signing the informed consent | 2024-2-26 |
Date of birth | 1987-6-8 yyyy-mm-dd |
Age | 36 Years |
Education background | Middle school
|
Occupation | Famer
|
Other (Description) | -- |
间断6天 小时 |
|
无 |
|
Number of pregnancy | 3 次 |
Number of delivery | 2 次 |
If has delivery history, select following items | |
partus maturus | 2 次 |
premature delivery | 0 次 |
abortion | 1 次 |
Last pregnancy | 9年前 yyyy-mm-dd |
Average times of menstrual onset a year | 12 次/年 |
Average menstrual cycle | 5.5 天(days) |
Menarche time | 13 岁(years) |
The time of last Menstruation | 2024-2-18 年、月、日(yyyy-mm-dd) |
The time of menstrual onset before the last one | 不详 年、月、日(yyyy-mm-dd) |
剖宫产2次 |
|
2009 2013 年/月/日(yyyy-mm-dd) |
|
Namy of the drug to be allergied | 无 |
Vulva | Normal
|
Description in detail for abnormal | -- |
Vagina | Normal
|
Description in detail for abnormal | -- |
Uterine neck | Normal
|
Description in detail for abnormal | -- |
Corpus uteri | Normal
|
Description in detail for abnormal | -- |
Adnexa uteri | |
Left side | Normal
|
Description in detail for abnormal | -- |
Right side | Abnormal
|
Description in detail for abnormal | 8*8*7cm包块 |
Weight | 70 kg |
Hight | 1620 mm |
Systolic pressure (SP) | 118 mmHg |
Diastolic pressure | 75 mmHg |
Temperature | 36.3 degree Celsius |
Pulse rate | 84 次/分 |
Breath frequency | 21 次/分 |
Doctor signature | 刘义彬 |
Date | 2024-2-26 yyyy-mm-dd |
WBC | 4.6 ×109 /L |
NEUT% | 57.95 % |
LY% | 32.76 % |
MONO% | 6.73 % |
RBC | 3.74 ×10^12 /L |
HGB | 108 g/L |
PLT | 279 ×10^9 /L |
Researcher signature | 刘义彬 |
Date | 2024-2-27 yyyy-mm-dd |
Acidity and allkalinity | Acidity
|
pH value | 6.5 |
Urine protein | Negative
|
Urine red cell | Negative
|
Urine WBC | Negative
|
Urine glucos | Negative
|
Urine Bilirubin | Negative
|
Urine HCG | |
KET | Negative
|
SG | 1.015 |
UBG | Negative
|
NIT | Negative
|
Date of test | 2024-2-27 yyyy-mm-dd |
Date of test | 2024-2-27 yyyy-mm-dd |
K | 4.05 mmol/L |
Na | 142.5 mmol/L |
Cl | 106.9 mmol/L |
Ca | 2.15 mmol/L |
P | 1.10 mmol/L |
Date of examination | 2024-2-27 yyyy-mm-dd |
Prothrombin time | 11.0 秒 |
Thrombin time (TT) | 13.6 秒 |
Activated partial thromboplastin time (APTT) | 29.8 秒 |
Fibrinogen (FIB) | 3.42 g/L |
ALT | 4.6 IU/L |
AST | 13.4 IU/L |
GGT | 14.0 U/L |
Serum bilirubin | 10.0 μmol/L |
Indirect bilirubin | 8.0 umol/L |
Direct bilirubin | 2.00 umol/L |
Serum albumin | 37.2 g/L |
Serum globulin | 28.2 g/L |
Serum total protein | 65.4 g/L |
Date of test | 2024-2-27 yyyy-mm-dd |
Negative
|
|
Date of test | 2024-2-27 yyyy-mm-dd |
Negative
|
|
Date of test | 2024-2-27 yyyy-mm-dd |
Negative
|
|
Date of test | 2024-2-27 yyyy-mm-dd |
Negative
|
|
Date of test | 2024-2-27 yyyy-mm-dd |
SCr | 49.0 μmol/L |
Blood urea | 3.30 mmol/L |
Blood uric acid | 231.0 μmol/L |
Date of test | 2024-2-27 yyyy-mm-dd |
D-dimer value | 0.19 ug/mL |
Date of test | 2024-2-27 |
Urine pregnancy test | Not tested
|
Blood HCG concentration | -- mIU/mL |
Date of test | -- yyyy-mm-dd |
Size of the ulcer | 5.19*5.78*4.77 cm*cm |
Uterine echo distribution | Not even
|
Endometrial thickness | 0.91 mm |
Left ovary size | 4.38*1.63 cm ×cm |
Shape of Left ovary | Normal
|
Size of the Ovarian cyst | -- |
Right ovary size | 8.96*7.0 cm ×cm |
Shape of right ovary | Ovarian cyst
|
Size of Ovarian cyst | 6.86 4.33cm |
Description of other abnormal findings | -- |
Diagnosis of the Ultrasound B | 右卵巢巧囊 |
Doctor signature | 刘义彬 |
Date of examination | 2024-2-24 yyyy-mm-dd |
Pain Visual Analogue Score | Rather pain tolerable
|
PH | 7.387 |
PCO2 | 39.6 mmHg |
P02 | 152.4 mmHg |
SO2 | 98.5 % |
HCO3 | 23.3 mmol/l |
SBE | -1.5 mmol/l |
LAC | 1.12 mmol/L |
Date of examination | 2024-3-1 (yyyy-mm-dd) |
右附件 |
|
9*9*8 cm |
|
顺时针 180 ° |
|
/ | |
刘义彬 |
|
2024-3-1 |
D-dimer value | 0.63 ug/mL |
Date of test | 2024-3-2 |
Body temperature | 37 ℃ |
Systolic pressure (SP) | 103 mmHg |
Diastolic pressure (DP) | 77 mmHg |
Heart Rate, HR | 84 次/分 |
Pulse | 84 次/秒 |
WBC | 10.90 ×109 /L |
NEUT% | 79.92 % |
LY% | 13.68 % |
MONO% | 6.27 % |
RBC | 3.64 ×10^12 /L |
HGB | 105 g/L |
PLT | 232 ×10^9 /L |
Date | 2024-3-2 yyyy-mm-dd |
/ | |
Pain Visual Analogue Score | Occasionally very slight pain
|
sample collection | Collected
|
Volume | 2 ml |
Time of collection | 2024-2-27 2024-3-2 yyyy-mm-dd-hh-min. |
Label Number of the sample | 2568295 |
Date received at DCC | -- yyyymmdd |
Report type | |
Name of this event | -- |
SAE start date | -- yyyymmdd |
SAE stop date | -- yyyymmdd |
Was this an unanticipated adverse event | |
Attribution to Study Drug | |
Outcome Type(check all that apply) | |
Recovery Description: (check only one) | |
Please provide a brief narrative of the SAE occurrence below | -- |
Name of the recorder |
|
Data | yyyymmdd |
Site Investigator’s signature |
|
Data | yyyymmdd |